cas 1246350-02-6|| where to buy 4-Chloro-3-cyclopropyl-1H-pyrazolo[4,3-c]pyridine

Produktname:4-Chloro-3-cyclopropyl-1H-pyrazolo[4,3-c]pyridine

IUPAC Name:4-chloro-3-cyclopropyl-1H-pyrazolo[4,3-c]pyridine

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM270654-1g	1-2 Weeks	ǆǠȌ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1246350-02-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1246350-02-6; Molekulare Formel:C9H8ClN3; Schmelzpunkt:-; SMILES-Code:ClC1=NC=CC2=C1C(C3CC3)=NN2; Dichte:

: Katalognummer:CM270654; Molekulargewicht:193.63; Siedepunkt:; Mdl-Nr.:MFCD28405414; Lagerung:

: Pyrazolopyridines; Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.